All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
When it comes to getting an injection in the eye, the fewer the better. That's what Regeneron Pharmaceuticals Inc. is counting on to drive its Eylea into the market for the neovascular form of age-related macular degeneration (wet AMD).